Myogesic Interactions
There are 561 drugs known to interact with Myogesic (magnesium salicylate / phenyltoloxamine), along with 13 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 25 are major, 504 are moderate, and 32 are minor.
- View all 561 medications that may interact with Myogesic
- View Myogesic alcohol/food interactions (1)
- View Myogesic disease interactions (13)
Most frequently checked interactions
View interaction reports for Myogesic (magnesium salicylate / phenyltoloxamine) and the medicines listed below.
- acetylcysteine
- Afrin (oxymetazoline nasal)
- Aldomet (methyldopa)
- allopurinol
- aluminum hydroxide / magnesium hydroxide / simethicone
- Amoclan (amoxicillin / clavulanate)
- amoxicillin / clavulanate
- aspirin
- Atacand (candesartan)
- atenolol
- Augmentin (amoxicillin / clavulanate)
- bisoprolol
- calcium citrate
- cefaclor
- cefixime
- cefuroxime
- Celebrex (celecoxib)
- Cipro (ciprofloxacin)
- ciprofloxacin ophthalmic
- clarithromycin
- clindamycin topical
- Coenzyme Q10 (ubiquinone)
- colchicine
- Copper (copper gluconate)
- Crestor (rosuvastatin)
- Crinone (progesterone)
- cyclosporine ophthalmic
- IBU (ibuprofen)
- norethindrone
- Paracetamol (acetaminophen)
Myogesic alcohol/food interactions
There is 1 alcohol/food interaction with Myogesic (magnesium salicylate / phenyltoloxamine).
Myogesic disease interactions
There are 13 disease interactions with Myogesic (magnesium salicylate / phenyltoloxamine) which include:
- GI toxicity
- renal dysfunction
- Reye's syndrome
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- hypermagnesemia
- anemia
- coagulation
- dialysis
- G-6-PD deficiency
- hepatotoxicity
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.